{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16720052", "DateCompleted": {"Year": "2007", "Month": "01", "Day": "18"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2006", "Month": "05", "Day": "04"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0166-3542", "JournalIssue": {"Volume": "72", "Issue": "2", "PubDate": {"Year": "2006", "Month": "Nov"}}, "Title": "Antiviral research", "ISOAbbreviation": "Antiviral Res"}, "ArticleTitle": "The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced by the hepatitis B virus-e antigen.", "Pagination": {"StartPage": "100", "EndPage": "106", "MedlinePgn": "100-6"}, "Abstract": {"AbstractText": ["The aim of this study is to characterize the role of ellagic acid, a flavonoid from a medicinal herb which blocks HBeAg secretion in a HBV infected cell line and in HBeAg transgenic mice, in immune tolerance in chronic HBV infection. Using the mouse strain C57ML/6, HBeAg-producing transgenic mice (HBeAg-Tg), under the control of metal ion-inducible promoter were generated. The effect on immune tolerance of HBeAg-Tg and the release of immune tolerance by the inhibitor of HBeAg secretion, ellagic acid, was tested using T/B cell proliferation, HBeAg/HBeAb production, cytotoxic T-lymphocyte (CTL) and cytokine assays. C57ML/6 based HBeAg-producing HBeAg-Tg mice were tolerant to HBeAg at the T and B-cell level, did not produce antibodies to HBeAg in vivo and in vitro, produced minimal levels of cytokines (IL-4 and IFN-gamma) and decreased CTL responses, while feeding mice with ellagic acid (5mg/kg body weight) blocked the immune tolerance caused by HBeAg. Our results suggest that host immune tolerance induced by HBeAg during HBV infection, a viral strategy to guarantee HBV infection, can be overcome by ellagic acid, thus it can be used as a therapeutic for HBV-carriers."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Liver Cell Signal Transduction Lab, Taejon, Republic of Korea."}], "Identifier": [], "LastName": "Kang", "ForeName": "Eun Hwa", "Initials": "EH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kown", "ForeName": "Tae Young", "Initials": "TY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Oh", "ForeName": "Goo Taeg", "Initials": "GT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Park", "ForeName": "Weung Feel", "Initials": "WF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Park", "ForeName": "Sung-Il", "Initials": "SI"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Park", "ForeName": "Sung Kyu", "Initials": "SK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "Young Ik", "Initials": "YI"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Antiviral Res", "NlmUniqueID": "8109699", "ISSNLinking": "0166-3542"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hepatitis B Antibodies"}, {"RegistryNumber": "0", "NameOfSubstance": "Hepatitis B e Antigens"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunologic Factors"}, {"RegistryNumber": "19YRN3ZS9P", "NameOfSubstance": "Ellagic Acid"}, {"RegistryNumber": "207137-56-2", "NameOfSubstance": "Interleukin-4"}, {"RegistryNumber": "82115-62-6", "NameOfSubstance": "Interferon-gamma"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["immunology"], "DescriptorName": "B-Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Cytotoxicity Tests, Immunologic"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Ellagic Acid"}, {"QualifierName": ["biosynthesis", "blood"], "DescriptorName": "Hepatitis B Antibodies"}, {"QualifierName": ["immunology"], "DescriptorName": "Hepatitis B e Antigens"}, {"QualifierName": ["immunology"], "DescriptorName": "Hepatitis B virus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Immune Tolerance"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Immunologic Factors"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Interferon-gamma"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Interleukin-4"}, {"QualifierName": [], "DescriptorName": "Lymphocyte Activation"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Transgenic"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["immunology"], "DescriptorName": "T-Lymphocytes"}, {"QualifierName": ["immunology"], "DescriptorName": "T-Lymphocytes, Cytotoxic"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "1", "Day": "26"}, {"Year": "2006", "Month": "4", "Day": "4"}, {"Year": "2006", "Month": "4", "Day": "4"}, {"Year": "2006", "Month": "5", "Day": "25", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "1", "Day": "19", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "5", "Day": "25", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16720052", "10.1016/j.antiviral.2006.04.006", "S0166-3542(06)00116-1"]}}], "PubmedBookArticle": []}